Tecentriq Injection

Introduction

Tecentriq is a medication that contains the active ingredient Atezolizumab. It is commonly referred to by its generic name.

Uses

Tecentriq is prescribed for the treatment of various types of cancer. It is specifically used to treat certain types of advanced or metastatic cancers, including lung cancer, bladder cancer, and certain types of breast cancer.

Dosage and Administration

The dosage of Tecentriq is determined by your healthcare provider and may vary depending on your specific condition. It is typically administered as an intravenous infusion over a certain period of time. Follow the prescribed dosage instructions and the recommended schedule for administration.

Mechanism of Action

Tecentriq belongs to a class of medications known as immune checkpoint inhibitors. It works by blocking a protein called PD-L1, which is found on some cancer cells. By blocking PD-L1, Tecentriq helps to activate the immune system and enhance its ability to recognize and destroy cancer cells.

Side Effects

Common side effects may include fatigue, diarrhea, nausea, decreased appetite, and rash. These side effects are usually mild and temporary. However, notify your healthcare provider if any side effects persist or worsen.

Serious side effects may occur less frequently but can include severe infusion reactions, pneumonitis (inflammation of the lungs), liver problems, and endocrine disorders. If you experience any serious side effects, seek immediate medical attention.

Drug Interactions

Tecentriq may interact with certain medications, including immunosuppressive agents. Inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements. Your healthcare provider will carefully consider these interactions when prescribing Tecentriq.

Precautions

Before using Tecentriq, inform your healthcare provider about any allergies you may have, as well as any other medical conditions you have or medications you are taking. Tecentriq may not be suitable for everyone, and your healthcare provider will assess the potential risks and benefits before prescribing it.

Avoid live vaccines while receiving Tecentriq. Additionally, Tecentriq may cause immune-related side effects, which can affect various organs in the body. Regular monitoring by your healthcare provider is essential to detect and manage any potential complications.

Storage

Patient Tips

• Attend all scheduled appointments with your healthcare provider for the administration of Tecentriq.
• Inform your healthcare provider about any new or worsening symptoms you experience while using this medication.
• Follow any additional instructions provided by your healthcare provider, such as dietary restrictions or activity limitations.
• If you have any concerns or questions about Tecentriq, do not hesitate to reach out to your healthcare provider for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Tecentriq 1,200 mg concentrate for solution for infusion (Health Professionals SmPC) Available at:
• Atezolizumab (Drugs.com) [Accessed 12 Jun. 2024] (online) Available at:
• atezolizumab solution (RX) [Accessed 16 Jun. 2024] (online) Available at:
• Atezolizumab Injection (MedlinePlus) [Accessed 28 Jun. 2024] (online) Available at:
• Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL; IMbrave150 Investigators. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745. [Accessed 29 Jun. 2024] Available at: